Alda appoints Beukman, Kennedy directors
2012-11-15 18:04 ET - News Release
Mr. Terrance Owen reports
NEW DIRECTORS JOIN THE BOARD OF ALDA
Eugene Beukman and Tom Kennedy have joined the board of directors of Alda Pharmaceuticals Corp., effective immediately.
Mr. Beukman is the corporate counsel of the Pender group of companies, a position he has held since January, 1994. He graduated from the Rand University of Johannesburg, South Africa, with a bachelor of law degree and a bachelor of law honours postgraduate degree in 1987. He has over 30 years experience in the acquisition of assets and joint ventures. He is president and director of a number of publically traded companies on the TSX Venture Exchange.
Mr. Kennedy is a graduate of the University of British Columbia, having received his bachelor of commerce and business administration degree in 1973 and his juris doctor degree in 1974. Mr. Kennedy was admitted to the B.C. bar in 1975 and has practised law for 36 years. After seven years of employment with the Canadian Federal Department of Justice, Mr. Kennedy has primarily focused as a legal, financial and business consultant to publicly traded companies. Mr. Kennedy is currently a member of the Law Society of British Columbia, the Canadian Bar Association and the British Columbia Bar Association and an associate member of the American Bar Association. Mr. Kennedy currently serves in positions as chief executive officer, president, vice-president and secretary of several TSX Venture Exchange and Canadian National Stock Exchange publicly traded companies, primarily focused on mineral exploration.
Mr. Beukman and Mr. Kennedy replace Dr. Ronald Zokol and Dr. Linda Allison, who have served as directors since 2003 and have resigned from the board as of Nov. 13, 2012. The company wishes to express its gratitude to Dr. Zokol and Dr. Allison for their long service as directors and wishes them well in their future endeavours.
We seek Safe Harbor.